Patents by Inventor Paolo Gatti

Paolo Gatti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210137899
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Application
    Filed: January 21, 2021
    Publication date: May 13, 2021
    Inventors: Luigi MAPELLI, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Publication number: 20200316042
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Application
    Filed: June 23, 2020
    Publication date: October 8, 2020
    Inventors: Luigi MAPELLI, Flavio FABIANI, Luigi BOLTRI, Paolo GATTI, Mauro SERRATONI, Roberto CASSANMAGNAGO
  • Patent number: 10729682
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: August 4, 2020
    Assignee: Adare Pharmaceuticals S.R.L.
    Inventors: Luigi Mapelli, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Publication number: 20200218228
    Abstract: A system for detecting and evaluating environmental quantities and events is formed by a detection and evaluation device and a mobile phone, connected through a wireless connection. The device is enclosed in a containment casing housing a support carrying a plurality of inertial sensors and environmental sensors. A processing unit is coupled to the inertial sensors and to the environmental sensors. A wireless connection unit, is coupled to the processing unit and a wired connection port, is coupled to the processing unit. A programming connector is coupled to the processing unit and is configured to couple to an external programming unit to receive programming instructions of the processing unit. A storage structure is coupled to the processing unit and a power-supply unit supplied power in the detection and evaluation device. The mobile phone stores an application, which enables a basicuse mode, an expert use mode, and an advanced use mode.
    Type: Application
    Filed: January 3, 2020
    Publication date: July 9, 2020
    Inventors: Luca FONTANELLA, Andrea LABOMBARDA, Marco BIANCO, Davide GHEZZI, Christian RAINERI, Paolo GATTI
  • Publication number: 20190076414
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Application
    Filed: November 9, 2018
    Publication date: March 14, 2019
    Inventors: Luigi Mapelli, Flavio FABIANI, Luigi BOLTRI, Paolo GATTI, Mauro SERRATONI, Roberto CASSANMAGNAGO
  • Patent number: 10166220
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: January 1, 2019
    Assignee: ADARE PHARMACEUTICALS S.R.L.
    Inventors: Luigi Mapelli, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Publication number: 20160081991
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Application
    Filed: December 2, 2015
    Publication date: March 24, 2016
    Inventors: Luigi Mapelli, Flavio FABIANI, Luigi BOLTRI, Paolo GATTI, Mauro SERRATONI, Roberto CASSANMAGNAGO
  • Patent number: 9233105
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: January 12, 2016
    Assignee: Adare Pharmaceuticals S.R.L.
    Inventors: Luigi Mapelli, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Publication number: 20140141091
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Application
    Filed: October 9, 2013
    Publication date: May 22, 2014
    Applicant: APTALIS PHARMA LIMITED
    Inventors: Luigi Mapelli, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Patent number: 8580313
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: November 12, 2013
    Assignee: Aptalis Pharma Limited
    Inventors: Luigi Mapelli, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Publication number: 20130274297
    Abstract: The invention provides a composite of drug, polymeric carrier and at least one not cross linked polymer useful to improve the solubility of poorly water soluble drugs. The present invention comprises manufacturing process of this composite material. The manufacturing process is carried out by the solvent induced activation process, wherein the not cross-linked polymer is loaded into the composite from organic solution, possibly together with the drug. Pharmaceutical compositions comprising said composite in combination with pharmaceutical acceptable excipients are also described herein.
    Type: Application
    Filed: December 22, 2011
    Publication date: October 17, 2013
    Applicant: APTALIS PHARMA LIMITED
    Inventors: Paolo Gatti, Italo Colombo, Dario Gervasoni, Vincenza Pironti, Lia Alborghetti, Flavio Fabiani, Luigi Boltri
  • Publication number: 20110311626
    Abstract: The present invention provides compositions comprising dicyclomine, or salts, and/or solvates and methods of making and using the compositions to treat intestinal hypermotility or Irritable Bowel Syndrome (IBS). The present invention also provides once-a-day orally disintegrating dosage forms comprising compositions of the present invention.
    Type: Application
    Filed: February 23, 2010
    Publication date: December 22, 2011
    Inventors: Gopi Venkatesh, Vincent Parrino, Paolo Gatti, Flavio Fabiani
  • Publication number: 20110250281
    Abstract: The present invention provides a pharmaceutical composition comprising taste-masked immediate release microcapsules which comprise fexofenadine and a water-insoluble polymer coating. These microcapsules and the pharmaceutical compositions comprising them have suitable drug content and desirable pharmaceutical properties, including a quick dissolution rate of fexofenadine combined with a taste masking effect.
    Type: Application
    Filed: December 2, 2010
    Publication date: October 13, 2011
    Applicant: Eurand Pharmaceuticals Limited
    Inventors: Luigi Mapelli, Flavio Fabiani, Luigi Boltri, Paolo Gatti, Mauro Serratoni, Roberto Cassanmagnago
  • Patent number: 7960582
    Abstract: The present invention relates to a new process for the resolution of mandelic acid derivatives from racemic mandelic acid derivative mixtures by salt formation with chiral base cyclic amides; to the resolved mandelic acid cyclic amide salts (see, for example, formula IIa), as well as certain other metal and amine salts of the mandelic acid derivatives, and to the use of the resolved mandelic acid derivatives as intermediates suitable for large-scale manufacturing of, for example, pharmaceutical compounds; Formula IIa, wherein R is selected from CHF2, H, C1-6 Alkyl, CH2F, CHCl2 and CClF2; and wherein n is 0, 1 or 2; R1 is H or C1-6 Alkyl and X is H, halo or C1-6 Alkyl.
    Type: Grant
    Filed: November 25, 2004
    Date of Patent: June 14, 2011
    Assignee: AstraZeneca AB
    Inventors: Hans Jorgen Blixt, Bo Lars Gustaf Bosson, Roberto Guiseppe Paolo Gatti, Simone Zaramella, Michael William Senior, Kurt Vogtli, Andrea Zistler
  • Publication number: 20080312457
    Abstract: The present invention relates to a new process for the resolution of mandelic acid derivatives from racemic mandelic acid derivative mixtures by salt formation with chiral base cyclic amides; to the resolved mandelic acid cyclic amide salts (see, for example, formula IIa), as well as certain other metal and amine salts of the mandelic acid derivatives, and to the use of the resolved mandelic acid derivatives as intermediates suitable for large-scale manufacturing of, for example, pharmaceutical compounds; Formula IIa, wherein R is selected from CHF2, H, C1-6 Alkyl, CH2F, CHCl2 and CClF2; and wherein n is 0, 1 or 2; R1 is H or C1-6 Alkyl and X is H, halo or C1-6 Alkyl.
    Type: Application
    Filed: November 25, 2004
    Publication date: December 18, 2008
    Inventors: Hans Jorgen Blixt, Bo Lars Gustaf Bosson, Roberto Guiseppe Paolo Gatti, Simone Zaramella, Michael William Senior, Kurt Vogtli, Andrea Zistler
  • Patent number: 7400195
    Abstract: A variable-gain amplifier with high input impedance includes positive and negative inputs, positive and negative outputs, first and second differential circuits and first, second and third impedances. The impedances form an impedance bridge between the outputs. The first and second differential circuits each have one input coupled to one of the inputs of the differential amplifier, one input coupled to the impedance bridge, and two outputs connected to the outputs of the differential amplifier. At least one of the impedances is a variable impedance.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: July 15, 2008
    Assignee: STMicroelectronics SA
    Inventor: Paolo Gatti
  • Patent number: 7312658
    Abstract: A differential amplifier having a first and second output terminals and receiving an input signal at an input terminal. The amplifier comprises a first amplifier having a first input connected to the input terminal, a second input and a first output connected together to the first output terminal, and a second output connected to the second output terminal, the first amplifier reproducing the input signal on the first output. The amplifier comprises a second amplifier having a first input receiving a reference signal and a second input connected to the output terminals by resistive elements and controlling the provision by the first amplifier on the second output of a signal such that the signals received at the first and second inputs of the second amplifier are equal.
    Type: Grant
    Filed: March 31, 2005
    Date of Patent: December 25, 2007
    Assignee: STMicroelectronics SA
    Inventors: Paolo Gatti, Marc Sabut
  • Publication number: 20060232336
    Abstract: A variable-gain amplifier with high input impedance includes positive and negative inputs, positive and negative outputs, first and second differential circuits and first, second and third impedances. The impedances form an impedance bridge between the outputs. The first and second differential circuits each have one input coupled to one of the inputs of the differential amplifier, one input coupled to the impedance bridge, and two outputs connected to the outputs of the differential amplifier. At least one of the impedances is a variable impedance.
    Type: Application
    Filed: April 14, 2006
    Publication date: October 19, 2006
    Inventor: Paolo Gatti
  • Publication number: 20050218981
    Abstract: A differential amplifier having a first and second output terminals and receiving an input signal at an input terminal. The amplifier comprises a first amplifier having a first input connected to the input terminal, a second input and a first output connected together to the first output terminal, and a second output connected to the second output terminal, the first amplifier reproducing the input signal on the first output. The amplifier comprises a second amplifier having a first input receiving a reference signal and a second input connected to the output terminals by resistive elements and controlling the provision by the first amplifier on the second output of a signal such that the signals received at the first and second inputs of the second amplifier are equal.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 6, 2005
    Inventors: Paolo Gatti, Marc Sabut
  • Publication number: 20040229930
    Abstract: The present invention features formulations of indolinones. The formulation is suitable for parenteral or oral administration, wherein the formulation comprises an indolinone, and a pharmaceutically acceptable carrier therefor. The formulations and the compounds themselves are useful for the treatment of protein kinase related disorders.
    Type: Application
    Filed: September 10, 2003
    Publication date: November 18, 2004
    Applicant: Pharmacia Italia S.p.A.
    Inventor: Paolo Gatti